Nijmegen, Netherlands

Arlette Vanderheijden


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arlette Vanderheijden: Innovator in Pharmaceutical Compositions

Introduction

Arlette Vanderheijden is a notable inventor based in Nijmegen, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly with her innovative work on amlodipine maleate compositions. Her research focuses on enhancing the stability of pharmaceutical formulations, which is crucial for effective medication delivery.

Latest Patents

Arlette holds 1 patent for her invention titled "Pharmaceutical compositions comprising amlodipine maleate." This patent describes a pharmaceutical composition that maintains good stability when formulated with a pH within the range of 5.5 to 7, measured as a 20 wt % aqueous slurry. The stability of the composition is further enhanced by utilizing amlodipine maleate particles with an average particle size greater than 20 microns, preferably exceeding 100 microns.

Career Highlights

Arlette is currently employed at Synthon B.V., a company known for its focus on developing complex pharmaceuticals. Her work at Synthon has allowed her to apply her innovative ideas in a practical setting, contributing to the advancement of pharmaceutical technologies.

Collaborations

Throughout her career, Arlette has collaborated with esteemed colleagues, including Jacobus Maria Lemmens and Frans Van Dalen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the pharmaceutical field.

Conclusion

Arlette Vanderheijden's contributions to pharmaceutical compositions exemplify her dedication to innovation in medicine. Her work not only enhances the stability of important medications but also showcases the impact of collaboration in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…